On March 12, 2025, Jennifer M. Kirk announced her resignation as Global Controller and Principal Accounting Officer of Medtronic, effective May 2, 2025, to become CEO of Exubrion Therapeutics; Denise L. Blomquist will succeed her starting March 17, 2025.